Washington University/B-JH/SLCH Consortium Program

The Adult Congenital Heart Disease (ACHD) Program at Washington University School of Medicine, part of the Barnes-Jewish Hospital/St. Louis Children’s Hospital consortium, provides specialized care tailored to adults with congenital heart defects. Since its founding in 1992, the program has evolved significantly to address the growing need for adult-specific treatment options for congenital heart defects.

Clinical Expertise

The ACHD program boasts a robust network of collaborative services which include cardiothoracic surgery, electrophysiology, interventional cardiology, advanced cardiac imaging (MRI, CT, PET/CT), and pulmonary hypertension management among other specialized areas. This comprehensive approach ensures that patients receive multidisciplinary care throughout their treatment journey, facilitating effective management of congenital conditions formerly treated during childhood.

Patients treated within this program include those who have undergone repairs in childhood and may require ongoing care, as well as those with unrepaired or newly diagnosed conditions that may present later in life.

Training Sites and Clinical Affiliations

The ACHD program collaborates closely with the following distinguished medical facilities:

• Barnes-Jewish Hospital
• St. Louis Children’s Hospital
• Center for Advanced Medicine
• Heart Care Institute

These partnerships allow for a seamless transition of care from pediatric to adult healthcare resources, emphasizing the program's commitment to continuity in patient management.

Research and Innovation

Within the ACHD program, there is a strong emphasis on clinical, basic, and translational research. This commitment to research enables the program to stay at the forefront of therapeutic advancements, contributing to an overall improved quality of care for patients with congenital heart defects. The research component includes participating in clinical trials and developing innovative solutions to complex medical challenges.

Application Requirements

Prospective candidates for the ACHD fellowship program should be aware that specific qualifications and experiences may impact their application. Important factors may include educational background, clinical exposure in congenital heart disease, and any prerequisite training. The program is highly competitive, welcoming applicants from both DO and IMG backgrounds, fostering an inclusive culture for medicine.

Visa Sponsorship and Support

For international medical graduates considering this program, the ACHD program offers support for various visa types. Typically, J-1 and H-1B visas may be sponsored, assisting qualified candidates in securing necessary legal documentation to pursue their training in the United States.

Competitiveness of the Program

The ACHD program is recognized as highly competitive, attracting a broad array of applicants globally. With its comprehensive training model and esteemed faculty, the program continuously seeks to cultivate a diverse cohort of fellows. This commitment not only enriches the training environment but also upholds the program's reputation as a leader in congenital heart disease management.

Unique Aspects of the Program

One of the distinguishing features of the ACHD program is its integration of adult and pediatric care, which many institutions do not provide. This unique approach enables a continuum of care for patients who transition from childhood care into adulthood, aligning clinical practices to address the specific challenges faced by adults with congenital heart conditions.

Comprehensive Training Curriculum

The curriculum within the ACHD fellowship includes a diverse array of clinical rotations, covering different subspecialties such as electrophysiology, cardiac surgery, heart failure, and transplant medicine, equipping fellows with a broad skill set necessary to manage complex cardiac cases.

Overall, the Washington University/Barnes-Jewish Hospital Consortium Program in Adult Congenital Heart Disease stands out not only for its dedicated focus on congenital heart defects but also for its commitment to innovative research, comprehensive care, and a collaborative clinical environment that nurtures the next generation of leading healthcare professionals.